Trial intelligence / Profile preview

Duration of Local Anesthetic in Dermatologic Surgery

NCT07724418Phase 4Not yet recruiting

Sponsor
Weill Cornell Medicine
Start
Nov 2026
Primary completion
May 2027
Countries
1
01

Overview

A Phase 4 trial of Lidocaine Hydrochloride Injection, without epinephrine, sponsored by Weill Cornell Medicine. Planned start Nov 2026; status: not yet recruiting.

02

Drugs

Lidocaine Hydrochloride Injection, without epinephrine

Beyond the preview

Go deeper on NCT07724418.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07724418.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call